With the aggressive pharmaceutical benefits manager Express Scripts lying in wait for two new cholesterol blockbuster contenders expected to debut this summer, the highly anticipated price war appears to already be well underway.

…read more

Source: The Gilead effect: PCSK9 rivals Amgen, Sanofi/Regeneron prep for a price war


0 No comments